Intravitreal bevacizumab (Avastin) associated with the regression of subretinal neovascularization in idiopathic juxtafoveolar retinal telangiectasis

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 245, Issue 7, 2006, Pages 1045-1048

  Jorge, Rodrigo ^a   Costa, Rogério A ^a,b   Calucci, Daniela ^b   Scott, Ingrid U ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Hospital de Olhos de Araraquara   (Brazil)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Bevacizumab; Juxtafoveolar telangiectasis; Subretinal neovascularization; VEGF

Indexed keywords

BEVACIZUMAB;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CASE REPORT; CENTRAL SCOTOMA; CLINICAL FEATURE; DRUG RESPONSE; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; IDIOPATHIC JUXTAFOVEOLAR RETINAL TELANGIECTASIA; METAMORPHOSIS; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA DISEASE; RETINA MACULA LUTEA; SINGLE DRUG DOSE; SUBRETINAL FLUID; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

EID: 34250849135     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-006-0468-2     Document Type: Article

References (9)

1. Costa RA, Jorge R, Calucci D, Cardillo JA, Melo Jr LAS, Scott IU (2006) Intravitreal bevacizumab (Avastin) for choroidal neovascularization caused by AMD (IBeNA Study): Results of a phase I dose-escalation study. Invest Ophthalmol Vis Sci 47:4569-4578
2. Engelbrecht NE, Aaberg TM Jr, Sung J, Lewis ML (2002) Neovascular membranes associated with idiopathic juxtafoveolar telangiectasis. Arch Ophthalmol 120(3):320-324
3. Gass JDM (1997) Retinal capillary diseases. In: Gass JDM (eds) Stereoscopic atlas of macular diseases: Diagnosis and treatment, 4th edn. CV Mosby, St. Louis, Missouri, pp 494-515
4. Potter MJ, Szabo SM, Chan EY, Morris AHC (2002) Photodynamic therapy of a subretinal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis. Am J Ophthalmol 133(1):149-151
5. Rosenfeld PJ, Moshfeghi AA, Puliafito CA (2005) Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 36(4):331-335
6. Shahar J, Avery RL, Heilweil G,Barak A,Zemel E,Lewis GP,Johnson PT,Fisher SK,Perlman I,Loewenstein A (2006) Electrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab (Avastin). Retina 26(3):262-269
7. Smithen LM, Spaide RF (2004) Photodynamic therapy and intravitreal triamcinolone for a subretinal neovascularization in bilateral idiopathic juxtafoveal telangiectasis. Am J Ophthalmol 138(5):884-886
8. Spaide RF, Laud K, Fine H,Klancnik JM Jr,Meyerle CB,Yannuzzi LA,Sorenson J,Slakter J,Fisher YL,Cooney MJ (2006) Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina 26(4):383-390
9. Yannuzzi LA, Bardal AM, Freund KB, Chen KJ, Eandi CM, Blodi B (2006) Idiopathic macular telangiectasia. Arch Ophthalmol 124(4):450-460